UNSPSC 51182053: Methandriol dipropionate

This classification denotes an anabolic steroid with the molecular formula C26H40O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8XIW70Q5I3. Most nations, for tariff and trade purposes, schedule methandriol dipropionate under HS 29372900 and SITC 54153. As of Q4 2014, METHANDRIOL DIPROPIONATE remains US FDA's Preferred Term for this commodity. Methandriol dipropionate bears US NLM identifiers UMLS ID C0770345 and NCI Concept Code C95962. SMILES: CCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@]4(C)OC(=O)CC)C)C.

UNSPSC 51182053 Methandriol dipropionate is a Commodity code that captures pharmaceutical manufacturing and supply contracts for generic multi-source drugs and over-the-counter products distributed through state and local government facilities. State and local procurement under this code centers on establishing multi-vendor supply agreements with manufacturers who can meet cGMP certification, Drug Supply Chain Security Act compliance, and stringent product-data requirements including NDC codes, SKUs, UPCs, and detailed dosage specifications. Issuing bodies include state departments of administration, multistate cooperative purchasing alliances, and member jurisdictions within those alliances; the source shows activity through Minnesota's MMCAP vehicle, which coordinates purchasing across participating state and local government facilities in Minnesota and Oregon.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 (solicitation S1070000015802) for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. MMCAP requires vendors to establish contractual relationships with at least two of three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—and mandates comprehensive insurance coverage including $5 million general liability and $2 million network security and privacy liability. The contract term runs two years for new responders with optional extensions, or through June 30, 2028 for incumbent responders, with awarded vendors taking effect July 1, 2026. Evaluation emphasizes price competitiveness at 75 percent weight, supported by fixed pricing, compliance with administrative data-format requirements, EDI capability, and acceptance of a 3 percent administrative fee on all purchases.